✦ LIBER ✦

Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: An exploratory study of the Gynecologic Oncology Group

✍ Scribed by Tewari, Krishnansu S.; Java, James J.; Gatcliffe, Troy A.; Bookman, Michael A.; Monk, Bradley J.

Book ID: 122146742
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 316 KB
Volume: 133
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2014.03.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term survival advantage of intraper

Long-term survival advantage of intraperitoneal chemotherapy treatment in advanced ovarian cancer: An analysis of a Gynecologic Oncology Group ancillary data study

✍ Tewari, D.; Java, J.; Salani, R.; Armstrong, D.; Markman, M.; Herzog, T.; Monk, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 60 KB

An exploratory analysis of HER-2 amplifi

An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group study

✍ T.A. Grushko; V.L. Filiaci; A.J. Mundt; K. Ridderstråle; O.I. Olopade; G.F. Flem 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 494 KB

The prognostic value of pretreatment CA

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma : A Gynecologic Oncology Group study

✍ Kristin K. Zorn; Chunqiao Tian; William P. McGuire; William J. Hoskins; Maurie M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

Assessment of tumor response as a surrog

Assessment of tumor response as a surrogate endpoint of survival in recurrent/platinum-resistant ovarian carcinoma: A Gynecologic Oncology Group study

✍ Peter G. Rose; Chunqiao Tian; Michael A. Bookman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Phase II trial of cisplatin as first-lin

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

✍ Jt Thigpen; JA Blessing; H Homesley; WT Creasman; G Sutton 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II trial of clsplatin as first-lin

Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group study

✍ J.Tate Thigpen; John A. Blessing; Howard Homesley; William T. Creasman; Gregory 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 331 KB